Business Description
Catalent Inc
NAICS : 325412
SIC : 2834
ISIN : US1488061029
Compare
Compare
Traded in other countries / regions
CTLT.USA0C8.GermanyCTLT.Mexico IPO Date
2014-07-31Description
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 1.37 | |||||
| Debt-to-EBITDA | -17.32 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.31 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1 | |||||
| 3-Year EPS without NRI Growth Rate | -59 | |||||
| 3-Year FCF Growth Rate | 39.7 | |||||
| 3-Year Book Growth Rate | -4.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 120.35 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 8.24 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.74 | |||||
| 9-Day RSI | 30.65 | |||||
| 14-Day RSI | 34.16 | |||||
| 6-1 Month Momentum % | 7.24 | |||||
| 12-1 Month Momentum % | 71.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.52 | |||||
| Quick Ratio | 1.93 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 80.88 | |||||
| Days Sales Outstanding | 74.5 | |||||
| Days Payable | 41.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2 | |||||
| Shareholder Yield % | -2.53 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 21.75 | |||||
| Operating Margin % | -1.42 | |||||
| Net Margin % | -23.81 | |||||
| FCF Margin % | -1.35 | |||||
| ROE % | -26.95 | |||||
| ROA % | -10.34 | |||||
| ROIC % | -0.68 | |||||
| 3-Year ROIIC % | -42.37 | |||||
| ROC (Joel Greenblatt) % | -16.78 | |||||
| ROCE % | -8.73 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 50.84 | |||||
| Shiller PE Ratio | 79.03 | |||||
| PS Ratio | 2.43 | |||||
| PB Ratio | 2.94 | |||||
| Price-to-Tangible-Book | 24.57 | |||||
| Price-to-Operating-Cash-Flow | 39.71 | |||||
| EV-to-EBIT | -19.77 | |||||
| EV-to-Forward-EBIT | 42.49 | |||||
| EV-to-EBITDA | -53.81 | |||||
| EV-to-Forward-EBITDA | 19.54 | |||||
| EV-to-Revenue | 3.49 | |||||
| EV-to-Forward-Revenue | 3.27 | |||||
| EV-to-FCF | -259.02 | |||||
| Price-to-Projected-FCF | 6.68 | |||||
| Price-to-Median-PS-Value | 1.04 | |||||
| Earnings Yield (Greenblatt) % | -5.06 | |||||
| FCF Yield % | -0.56 | |||||
| Forward Rate of Return (Yacktman) % | 4.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CTLT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Catalent Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,381 | ||
| EPS (TTM) ($) | -5.75 | ||
| Beta | 1.13 | ||
| Volatility % | 24.98 | ||
| 14-Day RSI | 34.16 | ||
| 14-Day ATR ($) | 0.455799 | ||
| 20-Day SMA ($) | 59.7695 | ||
| 12-1 Month Momentum % | 71.79 | ||
| 52-Week Range ($) | 32.38 - 61.2 | ||
| Shares Outstanding (Mil) | 181.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Catalent Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Catalent Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Catalent Inc Frequently Asked Questions
What is Catalent Inc(CTLT)'s stock price today?
The current price of CTLT is $58.48. The 52 week high of CTLT is $61.20 and 52 week low is $32.38.
When is next earnings date of Catalent Inc(CTLT)?
The next earnings date of Catalent Inc(CTLT) is 2024-11-15 Est..
Does Catalent Inc(CTLT) pay dividends? If so, how much?
Catalent Inc(CTLT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers